AVITA Medical, Inc. (RCEL)
13.20
-0.21
(-1.57%)
USD |
NASDAQ |
Oct 16, 12:23
AVITA Medical SG&A Expense (TTM) : 81.89M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 81.89M |
| March 31, 2026 | 83.32M |
| December 31, 2025 | 85.65M |
| September 30, 2025 | 82.72M |
| June 30, 2025 | 88.17M |
| March 31, 2025 | 91.01M |
| December 31, 2024 | 91.39M |
| September 30, 2024 | 88.12M |
| June 30, 2024 | 80.05M |
| March 31, 2024 | 72.39M |
| December 31, 2023 | 65.62M |
| September 30, 2023 | 59.32M |
| June 30, 2023 | 53.08M |
| March 31, 2023 | 47.72M |
| December 31, 2022 | 45.24M |
| September 30, 2022 | 43.00M |
| June 30, 2022 | 41.66M |
| March 31, 2022 | 37.86M |
| June 30, 2021 | 33.96M |
| March 31, 2021 | 34.86M |
| December 31, 2020 | 25.78M |
| September 30, 2020 | 18.78M |
| June 30, 2020 | 10.31M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 238.00M |
| Iovance Biotherapeutics, Inc. | 149.18M |
| Agenus, Inc. | 38.48M |
| Amgen, Inc. | 7.019B |
| Editas Medicine, Inc. | 45.51M |